These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 218903)

  • 1. Bovine enterovirus CPE at different multiplicities of infection in the absence of viral RNA synthesis.
    Levine RA; Wolff DA
    Intervirology; 1979; 11(4):255-60. PubMed ID: 218903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2-(alpha-hydroxybenzyl) benzimidazole (HBB) 5-iodo-2'-deoxyuridine (IUD) and actinomycin D on replication of strains of bovine enterovirus.
    Nath N; Balaya S; Mohapatra LN
    Indian Vet J; 1971 Jan; 48(1):1-5. PubMed ID: 4102705
    [No Abstract]   [Full Text] [Related]  

  • 3. Bovine enterovirus-1: characterization, replication and cytopathogenic effects.
    Taylor MW; Su R; Cordell-Stewart B; Morgan S; Crisp M; Hodes ME
    J Gen Virol; 1974 May; 23(2):173-8. PubMed ID: 4364878
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of enterovirus 71 infection of human cell lines.
    Wen YY; Chang TY; Chen ST; Li C; Liu HS
    J Med Virol; 2003 May; 70(1):109-18. PubMed ID: 12629651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of echovirus 9 on the enterovirus RNA replication inhibitor 2-(alpha-Hydroxybenzyl)-benzimidazole maps to nonstructural protein 2C.
    Hadaschik D; Klein M; Zimmermann H; Eggers HJ; Nelsen-Salz B
    J Virol; 1999 Dec; 73(12):10536-9. PubMed ID: 10559374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of enterovirus cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole.
    Bablanian R; Eggers HJ; Tamm I
    J Bacteriol; 1966 Mar; 91(3):1289-94. PubMed ID: 4956333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.
    Guskey LE; Smith PC; Wolff DA
    J Gen Virol; 1970 Jan; 6(1):151-61. PubMed ID: 4313397
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural requirements of selective inhibition of enteroviruses by 2-(alpha-hydroxybenzyl)-benzimidazole and related compounds.
    Tamm I; Eggers HJ; Bablanian R; Wagner AF; Folkers K
    Nature; 1969 Aug; 223(5208):785-8. PubMed ID: 5799019
    [No Abstract]   [Full Text] [Related]  

  • 9. Bovine enteroviruses: apparent correlation between antigenic characters and capacity to grow in the presence of small concentrations of 2-(alpha-hydroxybenzyl)-benzimidazole.
    Portolani M; Palenzona AM; Bernardini A; La Placa M
    Arch Gesamte Virusforsch; 1968; 24(4):428-32. PubMed ID: 4301716
    [No Abstract]   [Full Text] [Related]  

  • 10. [The action of 2(alpha-hydroxybenzyl)-benzimidazole on 26 strains of bovine enteroviruses isolated in Algeria (author's transl)].
    Vincent J
    Ann Microbiol (Paris); 1975 Sep; 126(2):255-7. PubMed ID: 175733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (AHC) by benzimidazoles; enviroxime (LY 122772) and enviradone (LY 127123).
    Langford MP; Ball WA; Ganley JP
    Antiviral Res; 1995 Aug; 27(4):355-65. PubMed ID: 8540755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the replication of a bovine enterovirus RNA.
    Todd D; Martin SJ
    J Gen Virol; 1979 Apr; 43(1):75-89. PubMed ID: 225421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of virus production in cells doubly infected with the virus of bovine diarrhea and a bovine enterovirus.
    Schiff LJ; Storz J
    Arch Gesamte Virusforsch; 1972; 36(3):218-25. PubMed ID: 4336489
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
    Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N
    Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical and serological characteristics of some New Zealand bovine enteroviruses.
    Durham PJ; Burgess GW
    Aust J Exp Biol Med Sci; 1979 Aug; 57(4):415-24. PubMed ID: 94546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel bovine enterovirus possessing highly divergent amino acid sequences in capsid protein.
    Tsuchiaka S; Rahpaya SS; Otomaru K; Aoki H; Kishimoto M; Naoi Y; Omatsu T; Sano K; Okazaki-Terashima S; Katayama Y; Oba M; Nagai M; Mizutani T
    BMC Microbiol; 2017 Jan; 17(1):18. PubMed ID: 28095784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and location of poliovirus macromolecular synthesis in correlation to virus-induced cytopathology.
    Bienz K; Egger D; Rasser Y; Bossart W
    Virology; 1980 Jan; 100(2):390-9. PubMed ID: 6243433
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of uncoated viral RNA following picornavirus infection.
    Tolbert O; Weaver B; Engler R
    Arch Gesamte Virusforsch; 1966; 19(2):221-9. PubMed ID: 4293033
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitric oxide inhibition of coxsackievirus replication in vitro.
    Zaragoza C; Ocampo CJ; Saura M; McMillan A; Lowenstein CJ
    J Clin Invest; 1997 Oct; 100(7):1760-7. PubMed ID: 9312175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the uncoating of bovine enterovirus by short chain fatty acids.
    Ismail-Cassim N; Chezzi C; Newman JF
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2283-9. PubMed ID: 2172446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.